!DOCTYPE html PUBLIC “-//W3C//DTD XHTML 1.1//EN” “http://www.w3.org/TR/xhtml11/DTD/xhtml11.dtd”>
CHAPTER 21 HEPARINIZING UNSTABLE ANGINA
Adding Heparin to Aspirin Reduces the Incidence of Myocardial Infarction and Death in Patients with Unstable Angina: A Meta-analysis
Oler A, Whooley MA, Oler J, et al. JAMA. 1996;276(10):811–815
BACKGROUND
Prospective studies had shown that 12% of patients hospitalized with unstable angina (UA) had an MI within 2 weeks with 1-year mortality ranging from 5% to 14% at the time of this study. Heparin had previously been shown to have benefit when used in patients with ST-elevation MI and during percutaneous coronary intervention, but prior randomized trials in the setting of UA had been unable to establish a definitive benefit of combination therapy regarding death or MI.
OBJECTIVES
To examine the effect on a composite endpoint of progression to MI or death in patients treated with heparin and aspirin compared to patients treated with aspirin alone.
METHODS
Meta-analysis of six studies conducted globally between the years 1966 and 1995.
Studies Included
Six randomized controlled trials, representing 1,353 patients, admitted with either UA or non–Q-wave MI.